Ellen Arruda, Ph.D., Lisa Larkin, Ph.D., and Edward Wojtys, MD
Third year of funding – 2012 funding: $120,371; funding to date $398,020
Ellen Arruda, Ph.D., Lisa Larkin, Ph.D., and Edward Wojtys, MD
Third year of funding – 2012 funding: $120,371; funding to date $398,020
James Ashton-Miller, Ph.D., William Chey, MD
$99,734
Omer Berenfeld, Ph.D., Hakan Oral, MD
Second year of funding – 2012 funding: S$120,511; funding to date $220,511
Joseph Bull, Ph.D., William Weitzel III MD
$110,000
Xudong (Sherman) Fan, Ph.D., John Younger, MD, MS
$100,000
Enzyme-linked immunosorbent assays (ELISA) have become a very widely used tool for the detection and quantification of various analytes. Despite its utility and longevity as a research and diagnostic tool, the price of such assays remains high. In part, this is due to costly reagents such Continue Reading »
Parag Patil, MD, Ph.D.
$100,000
Shuichi Takayama, Ph.D., Sophie Paczesny, MD, Ph.D.
Third Year of funding – 2012 funding: $110,105; funding to date $382,963
PHASIQ, founded in 2012 based on a Coulter-funded technology, supplies immunoassay kits and custom assay development to research scientists investigating protein biomarker patterns for human health.
Enzyme-linked immunosorbent assays (ELISA) have become a widely used Continue Reading »